“Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients”. 2026. Pakistan Journal of Medical & Cardiological Review 5 (1): 163-74. https://doi.org/10.5281/zenodo.18345788.